Trials / Not Yet Recruiting
Not Yet RecruitingNCT07114042
HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding
Moglobin, Albumin, Lymphocyte and Platelet Score as a Novel Predictor of Mortality and Re-bleeding in Patients With Upper Gastrointestinal Bleeding
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re\_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.
Detailed description
Study for evaluation of the utility of hemoglobin, Albumin, Lymphocyte and Platelat score in prediction of mortality and re\_bleeding in patient with upper gastrointestinal bleeding, Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Upper endoscopy | Prediction of upper gastrointestinal r\_bleeding and mortality |
Timeline
- Start date
- 2025-08-08
- Primary completion
- 2026-01-20
- Completion
- 2026-02-01
- First posted
- 2025-08-11
- Last updated
- 2025-08-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07114042. Inclusion in this directory is not an endorsement.